Dordaviprone (ONC201)
ONC012
Phase 2 small_molecule terminated
Quick answer
Dordaviprone (ONC201) for Endometrial Cancer Recurrent is a Phase 2 program (small_molecule) at Jazz Pharmaceuticals plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Jazz Pharmaceuticals plc
- Indication
- Endometrial Cancer Recurrent
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated